A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report
Abstract Background Metastatic cancer to the stomach is relatively rare. Prostate-specific antigen (PSA) is a reliable biomarker used in the screening and management of patients with prostate cancer. However, it is difficult to definitively diagnose a PSA-negative metastatic gastric tumor of prostat...
Saved in:
| Main Authors: | Koji Shindo, Kenoki Ohuchida, Taiki Moriyama, Fumio Kinoshita, Yutaka Koga, Yoshinao Oda, Masatoshi Eto, Masafumi Nakamura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Japan Surgical Society
2020-12-01
|
| Series: | Surgical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40792-020-01074-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Numerous lymph node metastases in early gastric cancer without preoperatively enlarged lymph nodes: a case report
by: Chikanori Tsutsumi, et al.
Published: (2020-01-01) -
CEA vaccines
by: Anchit Bhagat, et al.
Published: (2023-12-01) -
A case of high-grade prostate cancer with low PSA levels
by: Jan Bociański, et al.
Published: (2025-09-01) -
Prediction of Synchronous Serum CEA Expression Status Based on Baseline MRI Features of Primary Rectal Cancer Lesions Pre-treatment: A Retrospective Study
by: Baohua Lv, et al.
Published: (2024-12-01) -
CEA (CEACAM5) expression is common in muscle‐invasive urothelial carcinoma of the bladder but unrelated to the disease course
by: Henning Plage, et al.
Published: (2024-06-01)